Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Epidural Anesthetic Impact on Sevoflurane Consumption
NCT04021264Phase 3Withdrawn
- Sponsor
- University of Alberta
- Start
- Aug 2019
- Primary completion
- Jan 2022
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of ropivacaine, sufentanil in postoperative pain, sponsored by University of Alberta. Planned start Aug 2019; status: withdrawn.
02
Drugs
ropivacainesufentanil
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT04021264.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04021264.